Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 28.10.2026 FOCT.LN IE0004X8KUG5  100,002.00 USD   3,066,321.15   30.663  ...
-

Knack RCM Partners with Prosper AI to Redraw the Line Between Machine Work and Human Judgment in the Revenue Cycle

WOODBRIDGE, N.J. & MOHALI, India--(BUSINESS WIRE)--Knack RCM today announced a strategic partnership with Prosper AI to embed AI voice agents across Knack's revenue cycle delivery....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 28.10.2026 FJUL.LN IE000YJBT6I5  150,002.00 USD   4,437,208.09   29.581  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 28.10.2026 H2O LN IE000Q8F0M81  800,002.00 USD  15,800,859.16   19.751  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 28.10.2026 FJAN.LN IE000MDKBOB3  150,002.00 USD   4,476,309.17   29.842  ...
-

Starton Therapeutics Signs Clinical Trial Agreement with the Stanford School of Medicine to Evaluate STAR-LLD in Combination with Novel CAR-T Therapy for Multiple Myeloma

PARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary continuous delivery technologies, announced today that it has signed a clinical trial agreement with the Stanford School of Medicine to evaluate Starton’s lead candidate STAR-LLD, in combination with a novel CAR-T cell therapy for the treatment of multiple myeloma (MM).The planned study will investigate the safety and preliminary effi...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 28.10.2026 FAPR.LN IE000WX2HZQ7  200,002.00 USD   5,300,047.74   26.500  ...
-

Virgin Galactic Announces Date of Third Quarter 2026 Financial Results and Conference Call

ORANGE COUNTY, Calif.--(BUSINESS WIRE)--Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the "Company”) today announced that it will report its financial results for the third quarter of 2026 following the close of the U.S. markets on Thursday, November 12, 2026. Virgin Galactic will host a conference call to discuss the results that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).A live webcast and replay of the conference call will be available on the Company’s Investor...
-

Marcus Corporation Reports Third Quarter 2026 Results

MILWAUKEE--(BUSINESS WIRE)--The Marcus Corporation (NYSE: MCS) today reported results for the third quarter 2026 ended September 30, 2026. “Record third quarter revenue in both divisions drove the highest total revenue for any quarter in company history,” said Gregory S. Marcus, chief executive officer of Marcus Corporation. “In our theatre business, the successes continued with Marcus Theatres’ record third quarter revenue, powered by the blockbuster hits of Spider-Man: Brand New Day and The O...
-

Ranpak Holdings Corp. Reports Third Quarter 2026 Financial Results

CONCORD TOWNSHIP, Ohio--(BUSINESS WIRE)--Ranpak Holdings Corp. Reports Third Quarter 2026 Financial Results....